Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of T-817MA in post-stroke upper limb hemiplegia during rehabilitation
jRCT2031190110Phase 2Active, not recruiting
- Sponsor
- FUJIFILM Toyama Chemical
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stroke comparing T-817MA with Placebo (2 arms). Primary endpoint: Change from baseline in the total Fugl-Meyer Assessment upper limb motor function score. Started Jun 2019; status: active, not recruiting.
02
Drugs
edonerpic
03
Conditions
stroke
Beyond the preview
Go deeper on jRCT2031190110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031190110.